Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial.
Zivelonghi C, van Andel M, Venturi G, Amoroso G, Teeuwen K, Tijssen JGP, Tavella D, Ribichini F, Ten Berg JM, Resning BJ, Henriques JPS, Suttorp MJ, Agostoni P, Van der Schaaf RJ. Zivelonghi C, et al. Among authors: ribichini f. Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E81-E89. doi: 10.1002/ccd.27795. Epub 2018 Oct 2. Catheter Cardiovasc Interv. 2019. PMID: 30280464 Clinical Trial.
Risk stratification in acute coronary syndromes.
Pesarini G, Santini F, Geremia G, Zivelonghi C, Ribichini F. Pesarini G, et al. Among authors: ribichini f. J Cardiovasc Transl Res. 2012 Feb;5(1):1-10. doi: 10.1007/s12265-011-9337-4. Epub 2011 Dec 2. J Cardiovasc Transl Res. 2012. PMID: 22135119
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES).
Ribichini F, Tomai F, Pesarini G, Zivelonghi C, Rognoni A, De Luca G, Boccuzzi G, Presbitero P, Ferrero V, Ghini AS, Marino P, Vassanelli C; CEREA-DES Investigators. Ribichini F, et al. Eur Heart J. 2013 Jun;34(23):1740-8. doi: 10.1093/eurheartj/eht079. Epub 2013 Mar 14. Eur Heart J. 2013. PMID: 23492671 Clinical Trial.
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18. JACC Cardiovasc Interv. 2013. PMID: 24055444 Free article. Clinical Trial.
Asymptomatic severe aortic coarctation at old age.
Zivelonghi C, Pighi M, Perandini S, Vassanelli C, Ribichini F. Zivelonghi C, et al. Among authors: ribichini f. Int J Cardiol. 2014 May 15;173(3):e56-7. doi: 10.1016/j.ijcard.2014.03.096. Epub 2014 Mar 20. Int J Cardiol. 2014. PMID: 24704404 No abstract available.
Intracoronary optical coherence tomography: a review of clinical applications.
Zivelonghi C, Ghione M, Kilickesmez K, Loureiro RE, Foin N, Lindsay A, de Silva R, Ribichini F, Vassanelli C, Di Mario C. Zivelonghi C, et al. Among authors: ribichini f. J Cardiovasc Med (Hagerstown). 2014 Jul;15(7):543-53. doi: 10.2459/JCM.0000000000000032. J Cardiovasc Med (Hagerstown). 2014. PMID: 24922045 Review.
463 results